Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Pediatr Infect Dis J ; 43(6): 559-564, 2024 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-38380927

RESUMO

BACKGROUND: Prevention of early-onset neonatal sepsis (EONS) is a frequent reason why many newborns receive unnecessary antibiotics. The Sepsis Risk Calculator (SRC) was developed by the Kaiser Permanente Institute as a multivariate risk assessment of EONS, aiming to reduce laboratory testing and empiric neonatal antibiotic therapy. Our objective was to assess the potential of the SRC in reducing antibiotic use in our setting. METHODS: Late preterm and term newborns who received antibiotics from 2019 to 2020 in a tertiary Belgian hospital were included. Newborn-specific data were collected and entered into the online SRC, retrospectively calculating a sepsis risk score and providing recommendations for antibiotic administration. False-positive indications for treatment by the SRC were estimated based on previously published data. Antibiotic therapy rates according to the SRC recommendations were compared to the actual rate of antibiotic therapy. RESULTS: Of 5891 births, 414 newborns received antibiotics and were eligible for this study, representing a rate of 7.6% of newborns receiving antibiotics following our current guidelines. The SRC would have recommended antibiotic administration for 2.7%, reducing antibiotic therapy by 64.5%. Of 5 possible cases of EONS, 3 would have received antibiotics in the first 24 hours according to the SRC. CONCLUSIONS: In this Belgian cohort, use of the SRC has the potential to significantly decrease by 64.5% the newborns that receive antibiotics. This reduction would primarily concern asymptomatic newborns. If use of the SRC was to be implemented in Belgian maternities, strict clinical surveillance practices should be ensured.


Assuntos
Antibacterianos , Sepse Neonatal , Humanos , Recém-Nascido , Estudos Retrospectivos , Bélgica/epidemiologia , Antibacterianos/uso terapêutico , Sepse Neonatal/epidemiologia , Sepse Neonatal/tratamento farmacológico , Sepse Neonatal/prevenção & controle , Medição de Risco , Feminino , Masculino
2.
Pediatr Infect Dis J ; 42(9): 733-738, 2023 09 01.
Artigo em Inglês | MEDLINE | ID: mdl-37406181

RESUMO

BACKGROUND: Malaria is a major global public health concern in endemic countries and imported childhood malaria is increasing in malaria non-endemic countries. METHODS: This was a retrospective case review of all laboratory-confirmed malaria cases in children 0-16 years admitted between 2009 and 2019 in 2 large university teaching Hospitals in Brussels. RESULTS: A total of 160 children with a median age of 6.8 years (range 5-191 months) were included. We identified 109 (68%) children living in Belgium who had acquired malaria during their visit to malaria-endemic countries to visiting friends and relatives (VFRs), 49 children (31%) visitors or newly installed migrants, and 2 Belgian tourists. Peak seasonal incidence occurred between August and September. Plasmodium falciparum was responsible for 89% of all malaria cases. Almost 80% of children living in Belgium visited a travel clinic for advice, but only one-third reported having taken the prophylaxis schedule according to the recommendations. Based on WHO criteria, 31 children (19.3%) developed severe malaria; most of the patients with severe malaria were VFR travelers and were significantly younger, had higher leukocytosis, had more thrombocytopenia, higher CRP, and lower natremia compared with patients with an uncomplicated course. All children recovered fully. CONCLUSIONS: Malaria is a significant cause of morbidity among returning travelers and newly arrived immigrants to Belgium. Most of the children had an uncomplicated disease course. Physicians should educate families about traveling to malaria-endemic areas to correct malaria preventive measures and prophylaxis.


Assuntos
Emigrantes e Imigrantes , Malária , Humanos , Criança , Estudos Retrospectivos , Malária/prevenção & controle , Viagem , Plasmodium falciparum
3.
BMC Infect Dis ; 11: 100, 2011 Apr 20.
Artigo em Inglês | MEDLINE | ID: mdl-21507244

RESUMO

BACKGROUND: Asymptomatic nasopharyngeal carriage represents an important biological marker for monitoring pneumococcal serotype distribution and evaluating vaccine effects. Serotype determination by conventional method (Quellung reaction) is technically and financially challenging. On the contrary, PCR-based serotyping represents a simple, economic and promising alternative method. METHOD: We designed a novel multiplex PCR assay for specific detection of the 30 classical colonizing S. pneumoniae serogroups/types. This multiplex assay is composed of 7 consecutive PCR reactions and was validated on a large and recent collection of Streptococcus pneumoniae isolated during a prospective study conducted in Belgium at the time of PCV7 adoption. RESULTS: The multiplex PCR assay allowed the typing of more than 94% of the isolates of a collection of pneumococci isolated from Belgian preschool attendees (n = 332). Seventy-five percent of the isolates were typed after 3 subsequent PCR reactions. Results were in agreement with the Quellung identification. CONCLUSION: Our novel multiplex assay is an accurate and reliable method which can be used in place of the conventional method for S. pneumoniae carriage studies.


Assuntos
Cápsulas Bacterianas/genética , Portador Sadio/microbiologia , Reação em Cadeia da Polimerase/métodos , Streptococcus pneumoniae/classificação , Streptococcus pneumoniae/genética , Cápsulas Bacterianas/análise , Técnicas de Tipagem Bacteriana , Criança , Pré-Escolar , Humanos , Nasofaringe/microbiologia , Infecções Pneumocócicas/microbiologia , Reação em Cadeia da Polimerase/economia , Sorotipagem , Streptococcus pneumoniae/isolamento & purificação
4.
Pediatr Infect Dis J ; 32(1): 86-7, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23014357

RESUMO

Streptococcus pneumoniae serotype 1 presents a high invasiveness index and is seldom isolated from its niche, the nasopharynx. We report an unusual serotype 1 carriage in a healthy pediatric population at the time of the heptavalent pneumococcal vaccine adoption in Belgium. Our sampling period coincides with an epidemic wave of serotype 1 invasive pneumococcal infections. Invasive and colonizing isolates were characterized by both antibiotic resistance profile and multilocus sequence typing and were shown to share the same backbone (ST306 and ST350).


Assuntos
Portador Sadio/microbiologia , Infecções Pneumocócicas/microbiologia , Streptococcus pneumoniae/classificação , Bélgica/epidemiologia , Portador Sadio/epidemiologia , Criança , Pré-Escolar , Epidemias , Vacina Pneumocócica Conjugada Heptavalente , Humanos , Testes de Sensibilidade Microbiana , Tipagem de Sequências Multilocus , Infecções Pneumocócicas/epidemiologia , Vacinas Pneumocócicas , Estudos Prospectivos , Sorotipagem , Streptococcus pneumoniae/efeitos dos fármacos , Streptococcus pneumoniae/isolamento & purificação
5.
Int J Infect Dis ; 13(4): e153-5, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19010078

RESUMO

Kytococcus schroeteri is a newly described micrococcal species and, to date, has been associated mostly with endocarditis. Six infections attributable to this opportunistic pathogen have been described since 2002, when the first case was identified. We describe here the first pediatric case of a K. schroeteri ventriculoperitoneal shunt infection. The child was successfully treated with a combination of rifampin and vancomycin and shunt replacement. Initially identified as a Micrococcus spp. by both automated identification and conventional biochemical testing, sequencing of the 16S ribosomal RNA gene enabled accurate identification of the organism.


Assuntos
Infecções por Actinomycetales/etiologia , Derivação Ventriculoperitoneal/efeitos adversos , Actinomycetales/genética , Argélia , Antibacterianos/uso terapêutico , Pré-Escolar , Febre de Causa Desconhecida/tratamento farmacológico , Febre de Causa Desconhecida/etiologia , Humanos , Hidrocefalia/terapia , Masculino , RNA Bacteriano/genética , RNA Ribossômico 16S/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA